167 related articles for article (PubMed ID: 31684969)
1. Clinical, genetic, and molecular characterization of hyperphosphatasia with mental retardation: a case report and literature review.
Abi Farraj L; Khatoun WD; Abou Chebel N; Wakim V; Dawali K; Ghassibe-Sabbagh M
Diagn Pathol; 2019 Nov; 14(1):123. PubMed ID: 31684969
[TBL] [Abstract][Full Text] [Related]
2. PGAP3-related hyperphosphatasia with mental retardation syndrome: Report of 10 new patients and a homozygous founder mutation.
Abdel-Hamid MS; Issa MY; Otaify GA; Abdel-Ghafar SF; Elbendary HM; Zaki MS
Clin Genet; 2018 Jan; 93(1):84-91. PubMed ID: 28390064
[TBL] [Abstract][Full Text] [Related]
3. Hyperphosphatasia with mental retardation syndrome type 4 in three unrelated South African patients.
Bezuidenhout H; Bayley S; Smit L; Kinnear C; Möller M; Uren C; Urban MF
Am J Med Genet A; 2020 Oct; 182(10):2230-2235. PubMed ID: 32845056
[TBL] [Abstract][Full Text] [Related]
4. Hyperphosphatasia with mental retardation syndrome type 4 In two siblings-expanding the phenotypic and mutational spectrum.
Akgün Doğan Ö; Demir GÜ; Kosukcu C; Taskiran EZ; Simsek-Kiper PÖ; Utine GE; Alikaşifoğlu M; Boduroğlu K
Eur J Med Genet; 2019 Jun; 62(6):103535. PubMed ID: 30217754
[TBL] [Abstract][Full Text] [Related]
5. Delineating the phenotypic spectrum of hyperphosphatasia with mental retardation syndrome 4 in 14 patients of Middle-Eastern origin.
Balobaid A; Ben-Omran T; Ramzan K; Altassan R; Almureikhi M; Musa S; Al-Hashmi N; Al-Owain M; Al-Zaidan H; Al-Hassnan Z; Imtiaz F; Al-Sayed M
Am J Med Genet A; 2018 Dec; 176(12):2850-2857. PubMed ID: 30345601
[TBL] [Abstract][Full Text] [Related]
6. Rare Noncoding Mutations Extend the Mutational Spectrum in the PGAP3 Subtype of Hyperphosphatasia with Mental Retardation Syndrome.
Knaus A; Awaya T; Helbig I; Afawi Z; Pendziwiat M; Abu-Rachma J; Thompson MD; Cole DE; Skinner S; Annese F; Canham N; Schweiger MR; Robinson PN; Mundlos S; Kinoshita T; Munnich A; Murakami Y; Horn D; Krawitz PM
Hum Mutat; 2016 Aug; 37(8):737-44. PubMed ID: 27120253
[TBL] [Abstract][Full Text] [Related]
7. Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation.
Howard MF; Murakami Y; Pagnamenta AT; Daumer-Haas C; Fischer B; Hecht J; Keays DA; Knight SJ; Kölsch U; Krüger U; Leiz S; Maeda Y; Mitchell D; Mundlos S; Phillips JA; Robinson PN; Kini U; Taylor JC; Horn D; Kinoshita T; Krawitz PM
Am J Hum Genet; 2014 Feb; 94(2):278-87. PubMed ID: 24439110
[TBL] [Abstract][Full Text] [Related]
8. Mutations in PIGL in a patient with Mabry syndrome.
Fujiwara I; Murakami Y; Niihori T; Kanno J; Hakoda A; Sakamoto O; Okamoto N; Funayama R; Nagashima T; Nakayama K; Kinoshita T; Kure S; Matsubara Y; Aoki Y
Am J Med Genet A; 2015 Apr; 167A(4):777-85. PubMed ID: 25706356
[TBL] [Abstract][Full Text] [Related]
9.
Da'as SI; Aamer W; Hasan W; Al-Maraghi A; Al-Kurbi A; Kilani H; AlRayahi J; Zamel K; Stotland MA; Fakhro KA
Cells; 2020 Jul; 9(8):. PubMed ID: 32726939
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: a case report.
Fu L; Liu Y; Chen Y; Yuan Y; Wei W
BMC Pediatr; 2019 Feb; 19(1):68. PubMed ID: 30813920
[TBL] [Abstract][Full Text] [Related]
11. PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels.
Nakamura K; Osaka H; Murakami Y; Anzai R; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Kinoshita T; Matsumoto N; Saitsu H
Epilepsia; 2014 Feb; 55(2):e13-7. PubMed ID: 24417746
[TBL] [Abstract][Full Text] [Related]
12. Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.
Horn D; Wieczorek D; Metcalfe K; Barić I; Paležac L; Cuk M; Petković Ramadža D; Krüger U; Demuth S; Heinritz W; Linden T; Koenig J; Robinson PN; Krawitz P
Eur J Hum Genet; 2014 Jun; 22(6):762-7. PubMed ID: 24129430
[TBL] [Abstract][Full Text] [Related]
13. A Rare Variant in
Perez Y; Wormser O; Sadaka Y; Birk R; Narkis G; Birk OS
Biomed Res Int; 2017; 2017():3470234. PubMed ID: 29119105
[TBL] [Abstract][Full Text] [Related]
14. A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder.
Thompson MD; Knaus AA; Barshop BA; Caliebe A; Muhle H; Nguyen TTM; Baratang NV; Kinoshita T; Percy ME; Campeau PM; Murakami Y; Cole DE; Krawitz PM; Mabry CC
Eur J Med Genet; 2020 Apr; 63(4):103822. PubMed ID: 31805394
[TBL] [Abstract][Full Text] [Related]
15. Defining the phenotype of PGAP3-congenital disorder of glycosylation; a review of 65 cases.
Altassan R; Allers MM; De Graef D; Shah R; de Vries M; Larson A; Glamuzina E; Morava E
Mol Genet Metab; 2023 Nov; 140(3):107688. PubMed ID: 37647829
[TBL] [Abstract][Full Text] [Related]
16. Congenital diaphragmatic hernia and early lethality in PIGL-related disorder.
Winter-Paquette LM; Al Suwaidi HH; Sajjad Y; Bricker L
Eur J Med Genet; 2022 May; 65(5):104501. PubMed ID: 35378319
[TBL] [Abstract][Full Text] [Related]
17. PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
Krawitz PM; Murakami Y; Rieß A; Hietala M; Krüger U; Zhu N; Kinoshita T; Mundlos S; Hecht J; Robinson PN; Horn D
Am J Hum Genet; 2013 Apr; 92(4):584-9. PubMed ID: 23561847
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic analysis of two Chinese infants with Mabry syndrome.
Xue J; Li H; Zhang Y; Yang Z
Brain Dev; 2016 Oct; 38(9):807-18. PubMed ID: 27177984
[TBL] [Abstract][Full Text] [Related]
19. Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.
Krawitz PM; Murakami Y; Hecht J; Krüger U; Holder SE; Mortier GR; Delle Chiaie B; De Baere E; Thompson MD; Roscioli T; Kielbasa S; Kinoshita T; Mundlos S; Robinson PN; Horn D
Am J Hum Genet; 2012 Jul; 91(1):146-51. PubMed ID: 22683086
[TBL] [Abstract][Full Text] [Related]
20. A case of inherited glycosylphosphatidylinositol deficiency caused by PGAP3 variant with uniparental isodisomy on chromosome 17.
Mukai T; Kato S; Tanaka H; Kuroda Y; Kitaoka H; Ito A; Shitara Y; Kashima K; Takami H; Takahashi N; Kato M
Mol Genet Genomic Med; 2024 Jul; 12(7):e2452. PubMed ID: 38967264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
